Related Experiment Video
Updated: Jun 28, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
261
A CT-based radiomics nomogram for predicting histologic grade and outcome in chondrosarcoma
Xiaoli Li1, Xianglong Shi1, Yanmei Wang2
1Department of Radiology, The Affiliated Hospital of Qingdao University, No. 369, Shanghai Road, 266000, Qingdao, Qingdao, Shandong, China.
Summary
A CT-based radiomics nomogram (RN) accurately predicts chondrosarcoma (CS) tumor grade and patient outcomes. This tool aids in treatment planning and prognosis by identifying high-risk tumors and predicting recurrence-free survival.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Preoperative tumor grading in chondrosarcoma (CS) is vital for treatment and prognosis.
- Accurate grading aids in personalized treatment strategies and outcome prediction.
Purpose of the Study:
- To develop and validate a CT-based radiomics nomogram (RN) for preoperative chondrosarcoma (CS) grading.
- To assess the correlation between RN-predicted grade and patient outcomes, including recurrence-free survival (RFS).
Main Methods:
- 196 patients across three centers formed training (139) and validation (57) cohorts.
- A clinical model, radiomics signature (RS), and RN were developed and validated using AUC.
- Kaplan-Meier survival analysis assessed the association between RN-predicted grade and RFS.
Main Results:
- The RN (AUC, 0.842) and RS (AUC, 0.835) outperformed the clinical model (AUC, 0.776) in distinguishing low-grade from high-grade CS.
- A significant correlation was found between RN-predicted grade and RFS in both cohorts.
- High RN-predicted grade correlated with a 2.669-fold increased risk of recurrence (HR, 2.669).
Conclusions:
- The CT-based radiomics nomogram (RN) demonstrates strong performance in predicting chondrosarcoma (CS) histologic grade.
- The RN also effectively predicts patient outcomes, including recurrence-free survival.
- This tool holds promise for improving preoperative assessment and management of CS.

